In a recent appointment by Governor Greg Abbott, Randall Wright has been named to the Texas Pharmaceutical Initiative Governing Board. The initiative is looking to tackle the problem of rising costs for drugs and medical supplies within the public employee sector, with Wright's term set to extend until February 1, 2029. The announcement, made official yesterday, September 25, indicates a strategic move to leverage Wright’s extensive experience in healthcare to reshape the state's approach to pharmaceutical economics.
Having dedicated 46 years to healthcare before his retirement, Wright comes with a background tailored for such a daunting task. He held positions such as the executive vice president and chief operating officer of Texas Children’s Hospital, and the senior vice position at Houston Methodist Hospital. While working in the healthcare industry, Mr. Wright also served as a member in prestigious organizations including the American College of Healthcare Executives and the American Institute of Certified Public Accountants.
The information provided by the governor's office also notes Wright’s current involvement with the MD Anderson Cancer Center's Board of Visitors and his role in the Eastern Illinois University Foundation as a board member and vice chairman. Wright earned his Bachelor of Science in Physics from Eastern Illinois University, furthering his education with a Master of Business Administration from Southern Illinois University.
Complementing his professional track, Wright brings a spirit of community service to the board, having volunteered with Baker Ripley Houston.
